MCLE — Medicale Income Statement
0.000.00%
Last trade - 00:00- $0.65m
- $0.70m
Annual income statement for Medicale, fiscal year end - September 30th, USD millions except per share, conversion factor applied.
2020 September 30th | 2021 September 30th | R2022 September 30th | 2023 September 30th | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final |
| Revenue | ||||
| Total Revenue | 0 | 0 | 0 | 0 |
| Selling / General / Administrative Expenses | ||||
| Unusual Expense / Income | ||||
| Total Operating Expenses | 0.002 | 0.032 | 0.044 | 0.038 |
| Operating Profit | -0.002 | -0.032 | -0.044 | -0.038 |
| Net Income Before Taxes | -0.002 | -0.032 | -0.044 | -0.038 |
| Provision for Income Taxes | ||||
| Net Income After Taxes | -0.002 | -0.032 | -0.044 | -0.038 |
| Net Income Before Extraordinary Items | ||||
| Extraordinary Items | ||||
| Net Income | -0.002 | -0.032 | -0.046 | -0.037 |
| Income Available to Common Shareholders Excluding Extraordinary Items | ||||
| Income Available to Common Shareholders Including Extraordinary Items | ||||
| Diluted Net Income | -0.002 | -0.032 | -0.046 | -0.037 |
| Diluted Weighted Average Shares | ||||
| Basic EPS Including Extraordinary Items | ||||
| Diluted EPS Including Extraordinary Items | ||||
| Diluted EPS Excluding Extraordinary Items | ||||
| Normalised Income Before Taxes | ||||
| Normalised Income After Taxes | ||||
| Normalised Income Available to Common Shareholders | ||||
| Diluted Normalised EPS | -0.001 | -0.009 | -0.006 | -0.006 |